Browsing: Cognitive/neurodegenerative disorders
A new wireless system measuring fluctuations in the production of neurotransmitters could provide a way to automatically adjust stimulation patterns in real-time, according to patients’ responses.
This study investigates the use of PEGylated immunoliposomes prepared with anti-transferrin receptor OX26 and anti-α-synuclein LB509 antibodies, in an effort to overcome the blood-brain barrier and reach biological targets of Parkinson’s disease.
Mitochondrial impairment has previously been suggested to have an association with many neurodegenerative disorders. Discover more about how mitochondrial metals are disrupted in neurodegenerative diseases, and potential therapeutics aimed at restoring mitochondrial function.
A novel noninvasive light-based imaging technology could be utilized to monitor the effects of diseases such as Alzheimer’s and brain tumors on surrounding brain tissue.
Research suggests abnormal levels of Sac3 may precipitate Parkinson’s disease and hold key to future therapies.
A new study has highlighted the importance of immune system research in fighting Alzheimer’s disease.
Deborah Gustafson (State University of New York—Downstate Medical Center, NY, USA & University of Gothenburg, Sweden) discusses the complex relationship between BMI and dementia and evaluates the current literature within the epidemiological literature.